🧩 Step 5 — Concept Integration
This section integrates development, structure, function, disease mechanisms, and treatment into a single conceptual pathway. Focus on understanding how one event leads to another.
🧭 Whole Topic Core Flow
(Whole Topic Core Flow — Normal Function → Failure → Drug Action)
Stomach Structure Formation
↓
Proper embryological rotation → Formation of greater & lesser curvatures → Formation of lesser sac & stomach bed relations
↓
Normal arterial supply (celiac trunk branches) → Adequate gastric perfusion
↓
Functional gastric wall layers → Coordinated churning + secretion (acid & enzymes)
↓
Proper mucosal protection (mucus + blood supply) → Maintains gastric integrity
If Failure Occurs
Congenital rotation defect
→ Abnormal gastric positioning
→ Feeding difficulty / obstruction
OR
Reduced mucosal protection
→ Acid-induced mucosal injury
→ Gastritis / Peptic ulcer
OR
Vascular compromise
→ Reduced perfusion
→ Mucosal ischemia → Ulcer formation
Drug Action Integration
Proton pump inhibitors
→ Reduce acid secretion
→ Protect mucosa → Promote healing
H2 blockers
→ Decrease gastric acid output
Antacids
→ Neutralize acid
→ Provide symptomatic relief
Antibiotics (if H. pylori present)
→ Remove underlying cause
→ Prevent recurrence
⚙️ Core Mechanism Integration
(Primary Functional Breakdown Mechanism — Gastric Mucosal Injury)
Reduced mucus barrier
OR
Excess gastric acid secretion
↓
Hydrochloric acid reaches epithelial surface
↓
Damage to mucosal cells
↓
Local inflammation
↓
Ulcer formation
↓
Pain after meals
↓
Possible bleeding or perforation
Clinical Meaning:
Integrity of gastric mucosa depends on balance between acid secretion and mucosal defense.
🩺 Clinical Integration Snapshot
Flow 1 — Congenital Hypertrophic Pyloric Stenosis
Hypertrophy of pyloric circular muscle
↓
Narrowed pyloric canal
↓
Delayed gastric emptying
↓
Projectile vomiting in infants
↓
Dehydration & electrolyte imbalance
↓
Treatment:
Surgical pyloromyotomy
Flow 2 — Peptic Ulcer Disease
Excess acid + weak mucosal barrier
↓
Damage to gastric mucosa
↓
Ulcer formation
↓
Epigastric pain
↓
Possible bleeding
↓
Treatment:
Proton pump inhibitors + antibiotics (if H. pylori)
Flow 3 — Gastric Carcinoma Spread
Malignant transformation of gastric mucosa
↓
Tumor growth within stomach wall
↓
Spread through lymphatic drainage pathways
↓
Involvement of regional lymph nodes
↓
Systemic spread
↓
Management:
Surgery ± chemotherapy
🔥 Ultra–High–Yield Master Summary
(Last-Day Revision Model — System Integration)
Normal Function
Proper stomach development
+
Adequate blood supply
+
Functional mucosal glands
→ Efficient digestion
→ Mucosal protection
Disease Mechanism
Developmental error
→ Structural obstruction
OR
Reduced mucosal defense
→ Acid injury
→ Ulcer formation
OR
Abnormal cell growth
→ Tumor formation
→ Lymphatic spread
Drug Action
PPIs / H2 blockers
→ Reduce acid production
Antibiotics
→ Remove infection
Surgery
→ Correct structural obstruction
Treatment Effect
Restored gastric function
+
Reduced symptoms
+
Prevention of complications